Provided by Tiger Trade Technology Pte. Ltd.

Karyopharm Therapeutics

9.67
0.0000
Post-market: 9.670.00000.00%18:59 EST
Volume:312.60K
Turnover:3.00M
Market Cap:177.06M
PE:-0.54
High:9.82
Open:9.70
Low:9.40
Close:9.67
52wk High:10.38
52wk Low:3.51
Shares:18.31M
Float Shares:16.00M
Volume Ratio:0.22
T/O Rate:1.95%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-17.9300
EPS(LYR):-17.9300
ROE:-891.05%
ROA:-41.56%
PB:-0.60
PE(LYR):-0.54

Loading ...

Piper Sandler Reaffirms Their Buy Rating on Karyopharm Therapeutics (KPTI)

TIPRANKS
·
Feb 19

Karyopharm Therapeutics Price Target Maintained With a $15.00/Share by HC Wainwright & Co.

Dow Jones
·
Feb 18

Karyopharm Therapeutics Faces Rising Regulatory and Political Risks Amid Supreme Court Limits on FDA Authority

TIPRANKS
·
Feb 14

Analysts Offer Insights on Healthcare Companies: Sanofi (OtherSNYNF) and Karyopharm Therapeutics (KPTI)

TIPRANKS
·
Feb 14

UPDATE: Karyopharm Therapeutics Q4 Adj. EPS $(2.23) Misses $(1.99) Estimate

Benzinga
·
Feb 12

Karyopharm Therapeutics Showcases Pipeline Advances and Upcoming Phase 3 Data in Cancer Therapies

Reuters
·
Feb 12

BRIEF-Karyopharm Reports Fourth Quarter And Full Year 2025 Financial Results And Highlights Recent Company Progress

Reuters
·
Feb 12

Karyopharm Q4 revenue rises on XPOVIO demand

Reuters
·
Feb 12

Karyopharm Therapeutics Q4 EPS $(5.71) Misses $(1.99) Estimate, Sales $34.079M Miss $35.112M Estimate

Benzinga
·
Feb 12

Karyopharm reports FY 2025 total revenue of USD 146.07 million

Reuters
·
Feb 12

BRIEF-Karyopharm Therapeutics Q4 Net Income USD -102.198 Million

Reuters
·
Feb 12

Karyopharm Therapeutics Q4 Operating Expenses USD 51.923 Million

THOMSON REUTERS
·
Feb 12

Karyopharm Therapeutics Initiated at Overweight by Cantor Fitzgerald

Dow Jones
·
Feb 05

Karyopharm Therapeutics Inc. hat eine Aktualisierung ihres Finanzkalenders veröffentlicht

Reuters
·
Feb 05

Karyopharm initiated with an Overweight at Cantor Fitzgerald

TIPRANKS
·
Feb 05

BRIEF-Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule

Reuters
·
Feb 03

Karyopharm Therapeutics Grants RSUs to New Employees Under Inducement Plan

Reuters
·
Feb 03

Kristin Abate, Chief Accounting Officer, Reports Sale of Karyopharm Therapeutics Inc. Common Shares

Reuters
·
Jan 23

Analysts Are Bullish on These Healthcare Stocks: Intuitive Surgical (ISRG), Karyopharm Therapeutics (KPTI)

TIPRANKS
·
Jan 22

RBC Raises Price Target on Karyopharm Therapeutics to $23 From $19, Keeps Outperform Rating

MT Newswires Live
·
Jan 20